These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 23289972

  • 1. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.
    Navarrete-Vázquez G, Torres-Gómez H, Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Medina-Franco JL, León-Rivera I, Alarcón-Aguilar FJ, Almanza-Pérez JC.
    Bioorg Med Chem Lett; 2014 Sep 15; 24(18):4575-4579. PubMed ID: 25131539
    [Abstract] [Full Text] [Related]

  • 3. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A, Otto K, Hawkins E, Barr R, Bensch WR, Bull C, Dana S, Klausing K, Martin JA, Rafaeloff-Phail R, Rafizadeh-Montrose C, Rhodes G, Robey R, Rojo I, Rungta D, Snyder D, Wilbur K, Zhang T, Zink R, Warshawsky A, Brozinick JT.
    Mol Endocrinol; 2005 Jun 15; 19(6):1593-605. PubMed ID: 15831517
    [Abstract] [Full Text] [Related]

  • 4. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.
    Eur J Pharmacol; 2004 May 03; 491(2-3):195-206. PubMed ID: 15140637
    [Abstract] [Full Text] [Related]

  • 5. Triterpenoids from Hibiscus sabdariffa L. with PPARδ/γ Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.
    Giacoman-Martínez A, Alarcón-Aguilar FJ, Zamilpa A, Hidalgo-Figueroa S, Navarrete-Vázquez G, García-Macedo R, Román-Ramos R, Almanza-Pérez JC.
    Planta Med; 2019 Mar 03; 85(5):412-423. PubMed ID: 30650453
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ, Alam O, Alam MJ, Shaquiquzzaman M, Alam MM, Naidu VGM.
    Arch Pharm (Weinheim); 2018 Apr 03; 351(3-4):e1700223. PubMed ID: 29400412
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S, Alam MS, Hamid H, Shahar Yar M, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai K.
    Arch Pharm (Weinheim); 2015 Jun 03; 348(6):421-32. PubMed ID: 25900064
    [Abstract] [Full Text] [Related]

  • 8. Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent.
    Navarrete-Vázquez G, Alaniz-Palacios A, Hidalgo-Figueroa S, González-Acevedo C, Ávila-Villarreal G, Estrada-Soto S, Webster SP, Medina-Franco JL, López-Vallejo F, Guerrero-Álvarez J, Tlahuext H.
    Bioorg Med Chem Lett; 2013 Jun 01; 23(11):3244-7. PubMed ID: 23597793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
    Kouskoumvekaki I, Petersen RK, Fratev F, Taboureau O, Nielsen TE, Oprea TI, Sonne SB, Flindt EN, Jónsdóttir SÓ, Kristiansen K.
    J Chem Inf Model; 2013 Apr 22; 53(4):923-37. PubMed ID: 23432662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A, Wu L, Wang R, de Champlain J.
    Am J Hypertens; 2006 Apr 22; 19(4):407-12. PubMed ID: 16580578
    [Abstract] [Full Text] [Related]

  • 18. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes.
    Kotowska D, El-Houri RB, Borkowski K, Petersen RK, Fretté XC, Wolber G, Grevsen K, Christensen KB, Christensen LP, Kristiansen K.
    Planta Med; 2014 Dec 22; 80(18):1712-20. PubMed ID: 25371981
    [Abstract] [Full Text] [Related]

  • 19. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
    Choi SS, Kim ES, Koh M, Lee SJ, Lim D, Yang YR, Jang HJ, Seo KA, Min SH, Lee IH, Park SB, Suh PG, Choi JH.
    J Biol Chem; 2014 Sep 19; 289(38):26618-26629. PubMed ID: 25100724
    [Abstract] [Full Text] [Related]

  • 20. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
    Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA.
    Diabetes; 2006 Sep 19; 55(9):2523-33. PubMed ID: 16936200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.